Targeting the epigenome in in-stent restenosis: from mechanisms to therapy
Coronary artery disease (CAD) is one of the most common causes of death worldwide. The introduction of percutaneous revascularization has revolutionized the therapy of patients with CAD. Despite the advent of drug-eluting stents, restenosis remains the main challenge in treating patients with CAD. I...
Saved in:
Main Authors: | Xi Yang (Author), Yanyan Yang (Author), Junjie Guo (Author), Yuanyuan Meng (Author), Min Li (Author), Panyu Yang (Author), Xin Liu (Author), Lynn Htet Htet Aung (Author), Tao Yu (Author), Yonghong Li (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanocarrier Design for Dual-Targeted Therapy of In-Stent Restenosis
by: Ivan S. Alferiev, et al.
Published: (2024) -
piRNA-823 is a novel potential therapeutic target in aortic dissection
by: Min Li, et al.
Published: (2023) -
Albumin to globulin ratio was associated with in‐stent restenosis and revascularization events after percutaneous coronary intervention
by: Rui Zhang, et al.
Published: (2022) -
Gene Therapy for the Prevention of in- Stent Restenosis Post Coronary Angioplasty
by: P Ranjzad, et al.
Published: (2005) -
Gene Therapy for the Prevention of in- Stent Restenosis Post Coronary Angioplasty
by: P Ranjzad, et al.
Published: (2005)